Aflac (NYSE:AFL - Get Free Report) had its price objective reduced by research analysts at Keefe, Bruyette & Woods from $108.00 to $107.00 in a research report issued on Friday,Benzinga reports. The firm presently has a "market perform" rating on the financial services provider's stock. Keefe, Bruyette & Woods' target price would suggest a potential upside of 5.93% from the company's previous close.
AFL has been the topic of a number of other research reports. Piper Sandler increased their price target on shares of Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. Wells Fargo & Company raised their price objective on shares of Aflac to $107.00 and gave the stock a "hold" rating in a report on Tuesday, December 3rd. Bank of America upped their price target on Aflac from $115.00 to $124.00 and gave the stock a "buy" rating in a research report on Thursday, October 10th. Barclays raised their price objective on shares of Aflac from $96.00 to $98.00 and gave the company an "underweight" rating in a research report on Monday. Finally, TD Cowen initiated coverage on Aflac in a research note on Wednesday, October 9th. They issued a "hold" rating and a $102.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, Aflac currently has a consensus rating of "Hold" and an average target price of $102.29.
Read Our Latest Analysis on AFL
Aflac Price Performance
Shares of Aflac stock traded down $2.56 on Friday, hitting $101.01. 2,176,298 shares of the company traded hands, compared to its average volume of 1,691,163. The firm's 50-day simple moving average is $106.63 and its 200 day simple moving average is $104.72. Aflac has a 12-month low of $75.07 and a 12-month high of $115.50. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.32. The company has a market cap of $56.11 billion, a P/E ratio of 15.21, a P/E/G ratio of 2.09 and a beta of 1.00.
Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.47. The business had revenue of $2.95 billion for the quarter, compared to analysts' expectations of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business's quarterly revenue was down 40.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.84 EPS. Analysts expect that Aflac will post 7.27 earnings per share for the current fiscal year.
Insider Transactions at Aflac
In other news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company's stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.90% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in AFL. Y.D. More Investments Ltd acquired a new position in shares of Aflac during the 2nd quarter valued at $25,000. Darwin Wealth Management LLC acquired a new stake in shares of Aflac during the third quarter worth $34,000. Raelipskie Partnership acquired a new stake in Aflac during the third quarter worth about $38,000. Covestor Ltd raised its position in shares of Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock worth $41,000 after purchasing an additional 107 shares during the period. Finally, Kennebec Savings Bank bought a new stake in Aflac in the third quarter valued at $45,000. Institutional investors and hedge funds own 67.44% of the company's stock.
Aflac Company Profile
(
Get Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.